Combination of novel agents with radiotherapy to treat rectal cancer
Neoadjuvant chemoradiotherapy with fluoropyrimidines is an established treatment in the management of locally advanced rectal cancer. There has been a great deal of research into improving patient outcomes by modifying this regimen by the addition of further radiosensitising agents. One of the diffi...
| Hauptverfasser: | , , |
|---|---|
| Format: | Journal article |
| Veröffentlicht: |
WB Saunders
2015
|